Champions Oncology Stock Forecast

Sell candidate since Jun 02, 2026 Loss -0.61%

The Champions Oncology stock price fell by -0.611% on the last day (Wednesday, 3rd Jun 2026) from $5.73 to $5.69. During the last trading day the stock fluctuated 2.32% from a day low at $5.61 to a day high of $5.74. The price has fallen in 7 of the last 10 days and is down by -4.85% for this period. Volume has increased on the last day by 9 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 13 thousand shares were bought and sold for approximately $72.83 thousand.

The stock has broken the horizontal trend down. Breaks like this are often followed by swift and strong movements, and any correction down to the breakline at approximately $5.76 is considered to be a "second chance" to get out before further fall. It is, however, important to note that false breaks may appear and that the price may move back into the horizontal trend. A break on increasing volume is considered to be more significant and reliable than breaks on low volume.

CSBR Signals & Forecast

There are few to no technical positive signals at the moment. The Champions Oncology stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.83 and $5.98. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 14, 2026, and so far it has fallen -8.37%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Champions Oncology gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Champions Oncology stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.130 (2.32%) between high and low. For the last week, the stock has had daily average volatility of 2.72%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CSBR) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Champions Oncology to open at $5.68, and during the day (based on 14 day Average True Range), to move between $5.57 and $5.81, which gives a possible trading interval of +/-$0.230 (+/-4.13%) up or down from last closing price. If Champions Oncology takes out the full calculated possible swing range there will be an estimated 4.13% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $5.75, some $0.0600 (1.05%) from the current price of $5.69, our system finds the risk reward not very attractive.

Is Champions Oncology stock A Buy?

Champions Oncology holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.687 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $5.68 ( 0.176%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk